Gingivitis Pipeline Review, H2 2020 Report Featuring Amyndas Pharmaceuticals, Avicanna, & Pacgen Life Science – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Gingivitis – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Gingivitis Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Gingivitis (Mouth And Dental Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Gingivitis (Mouth And Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gingivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Discovery stages are 2 and 1 respectively. Similarly, the Universities portfolio in Phase II stages comprises 2 molecules, respectively.
Gingivitis (Mouth And Dental Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Gingivitis (Mouth And Dental Disorders).
- The pipeline guide reviews pipeline therapeutics for Gingivitis (Mouth And Dental Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Gingivitis (Mouth And Dental Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Gingivitis (Mouth And Dental Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Gingivitis (Mouth And Dental Disorders)
Key Topics Covered:
Introduction
Gingivitis – Overview
Gingivitis – Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
Gingivitis – Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
Gingivitis – Companies Involved in Therapeutics Development
- Amyndas Pharmaceuticals LLC
- Avicanna Inc
- Pacgen Life Science Corp
Gingivitis – Drug Profiles
AMY-101 – Drug Profile
- Product Description
- Mechanism Of Action
- R&D Progress
BLXA-4ME – Drug Profile
- Product Description
- Mechanism Of Action
- R&D Progress
KSL-W – Drug Profile
- Product Description
- Mechanism Of Action
- R&D Progress
P-113 – Drug Profile
- Product Description
- Mechanism Of Action
- R&D Progress
Small Molecules to Agonise CB1 and CB2 for Gingivitis – Drug Profile
- Product Description
- Mechanism Of Action
- R&D Progress
Gingivitis – Dormant Projects
Gingivitis – Product Development Milestones
- Featured News & Press Releases
- Aug 26, 2019: Amyndas Pharmaceuticals initiates phase 2a study of AMY-101 in adults with periodontal inflammation and gingivitis
- Jan 24, 2017: Pacgen announces new markets for P113 products
Appendix
Companies Mentioned
- Amyndas Pharmaceuticals LLC
- Avicanna Inc
- Pacgen Life Science Corp
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/f1y4gd
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
